Iladatuzumab vedotin (anti-CD79b), is an antibody-drug conjugate (ADC) composed of CD79B (immunoglobulin-associated CD79 beta) antibody and cytotoxic agent monomethyl auristatin E (MMAE) conjugated through maleimidocaproyl-valyl-citrullinyl-p-aminobenzyloxycarbonyl (mc-val-cit-PABC) type linker. Iladatuzumab vedotin (anti-CD79b) has the potential for B-cell non-Hodgkin lymphoma (B-NHL) research.
规格
产品名称
Iladatuzumab vedotin (anti-CD79b)
英文别名
AGM6 antibody | B cell antigen receptor complex associated protein beta chain antibody | B cell specific glycoprotein B29 antibody | B-cell antigen receptor complex-associated protein beta chain antibody | B-cell-specific glycoprotein B29 antibody | B29 a
Supplied as a 0.22μm filtered solution in 100mM Pro-Ac, 20mM Arg, pH 5.0
防腐剂
No
储存条件
-80℃储存,避免反复冻融
运输条件
特低温运输
稳定性与储存
在 -80℃ 下保存 24 个月。收货后建议分装。避免冷冻/解冻循环。
图片
Iladatuzumab vedotin (anti-CD79b) (Ab183320) - ELISA Immobilized Recombinant Human CD79B protein (rp176729) at 1.0 μg/mL can bind Iladatuzumab vedotin (anti-CD79b) (Ab183320) with the EC50 of 47.25 ng/mL.
Iladatuzumab vedotin (anti-CD79b) (Ab183320) - SEC The purity of Iladatuzumab vedotin (anti-CD79b) (Ab183320) is more than 95% verified by HPLC.